Polycystic ovarian syndrome
Barrea, L., Arnone, A., Annunziata, G., Muscogiuri, G., Laudisio, D., Salzano, C., Pugliese, G., Colao, A., and Savastano, S. (2019). Adherence to the Mediterranean diet, dietary patterns and body composition in women with Polycystic Ovary Syndrome (PCOS). Nutrients;11(10):2278. doi: 10.3390/nu11102278. PMID: 31547562; PMCID: PMC6836220.
Cooney LG, Dokras A. (2018). Beyond fertility: Polycystic ovary syndrome and long‑term health. Fertil Steril; 110:794‑809.
de Melo, A., Dias, S., Cavalli, R., Cardoso, V., Bettiol. H/, Barbieri. M., et al. (2015). Pathogenesis of polycystic ovary syndrome: Multifactorial assessment from the foetal stage to menopause. Reproduction; 150:R11‑24.
Haidari, F., Banaei-Jahromi, N., Zakerkish, M., Ahmadi, K. (2020). The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial. Nutrition Journal;19(1):8. doi: 10.1186/s12937-020-0524-5. PMID: 31980022; PMCID: PMC6982376.
Krishnan A, Muthusami S. (2017). Hormonal alterations in PCOS and its influence on bone metabolism. J Endocrinol; 232:R99‑R113.
Minooee S, Ramezani Tehrani F, Rahmati M, Mansournia MA, Azizi F. (2018). Prediction of age at menopause in women with polycystic ovary syndrome. Climacteric; 21:29‑34.
Palomba S, Santagni S, Falbo A, La Sala GB. (2015). Complications and challenges associated with polycystic ovary syndrome: Current perspectives. Int J Womens Health; 7:745‑63.
Patel SM, Ratcliffe SJ, Reilly MP, Weinstein R, Bhasin S, Blackman MR, et al. (2009). Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J Clin Endocrinol Metab; 94:4776‑84.
Puurunen J, Piltonen T, Jaakkola P, Ruokonen A, Morin‑Papunen L, Tapanainen JS. (2009). Adrenal androgen production capacity remains high up to menopause in women with polycystic ovary syndrome. J Clin Endocrinol Metab; 94:1973‑8.
Schmidt J, Landin‑Wilhelmsen K, Brännström M, Dahlgren E. (2011). Cardiovascular disease and risk factors in PCOS women of postmenopausal age: A 21‑year-controlled follow‑up study. J Clin Endocrinol Metab; 96:3794‑803.
Sharma, S., Mahajan, N. (2021). Polycystic Ovarian Syndrome and Menopause in Forty Plus Women. Journal of Midlife Health; 12(1):3-7. doi: 10.4103/jmh.jmh_8_21. Epub 2021 Apr 17. PMID: 34188419; PMCID: PMC8189332.
Zhao L, Li W, Han F, Hou L, Baillargeon JP, Kuang H, et al. (2011). Berberine reduces insulin resistance induced by dexamethasone in theca cells in vitro. Fertil Steril; 95:461‑3.
https://www.nhs.uk/conditions/polycystic-ovary-syndrome-pcos/
Recommendations
Compiled by Women’s Hormonal Health & Wellness, PLLC
Margaret Goddard, APRN-CNP